Advances in magnetic resonance imaging of brain tumours

Current Opinion in Neurology

Volumn 16, Issue 6, 2003, Pages 643-650

  Rees, Jeremy ^a  

^a NATIONAL HOSPITAL FOR NEUROLOGY AND NEUROSURGERY   (United Kingdom)

Author keywords

Brain tumour; Glioma; Imaging; Magnetic resonance imaging

Indexed keywords

BRAIN ABSCESS; BRAIN METASTASIS; BRAIN TUMOR; CANCER RADIOTHERAPY; DIFFUSION TENSOR IMAGING; DIFFUSION WEIGHTED IMAGING; GLIOMA; HUMAN; HYPOPHYSIS TUMOR; INTRAOPERATIVE PERIOD; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PERFUSION WEIGHTED IMAGING; REVIEW; WHITE MATTER;

BRAIN; BRAIN NEOPLASMS; DIAGNOSIS, DIFFERENTIAL; DIFFUSION MAGNETIC RESONANCE IMAGING; HUMANS; MAGNETIC RESONANCE IMAGING; MONITORING, INTRAOPERATIVE; PREDICTIVE VALUE OF TESTS;

EID: 1842506972     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019052-200312000-00001     Document Type: Review

References (36)

1. Pobereskin LH, Chadduck JB. Incidence of brain tumours in two English counties: a population based study. J Neurol Neurosurg Psychiatry 2000; 69:464-471.
2. Kondziolka D, Lunsford D, Julio Martinez A. Unreliability of contemporary neurodiagnostic imaging in evaluating suspected adult supratentorial (low-grade) astrocytoma. J Neurosurg 1993; 79:533-536.
3. Leclerc X, Huisman AGM, Sorensen AG. The potential of proton magnetic resonance spectroscopy (1H-MRS) in the diagnosis and management of patients with brain tumors. Curr Opin Oncol 2002; 14:292-298. A thorough review of the theory and applications of MRS in neuro-oncology is presented.
4. Kaminogo M, Ishimaru H, Morikawa M, et al. Diagnostic potential of short echo time MR spectroscopy of gliomas with single-voxel and point-resolved spatially localized proton spectroscopy of brain. Neuroradiology 2001; 43:353-363.
5. 1H-MRS be of clinical value? Br J Radiol 2003; 76:459-463.
6. Howe FA, Barton SJ, Cudlip SA, et al. Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Res Med 2003; 49:223-232. This is a well conducted and careful quantitative study of the differing spectral profiles in various types of brain tumours.
7. Tate AR, Majȯs C, Moreno A, et al. Automated classification of short echo time in in vivo 1H brain tumor spectra: a multicentre study. Magn Res Med 2003; 49:29-36. This is the first report of the use of pattern recognition algorithms to ease the interpretation of spectra acquired from brain tumours using a variety of different acquisition parameters.
8. Lai PH, Ho JT, Chen WL, et al. Brain abscess and necrotic brain tumor: discrimination with proton MR spectroscopy and diffusion-weighted imaging. AJNR Am J Neuroradiol 2002; 23:1369-1377.
9. 1HMRS) to clinical brain tumour diagnosis. Br J Neurosurg 2002; 16:329-334.
10. Kono K, Inoue Y, Nakayama K, et al. The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuradiol 2001; 22:1081-1088.
11. Yang D, Korogi Y, Suguhara T, et al. Cerebral gliomas: prospective comparison of multivoxel 2D chemical shift imaging, proton MR spectroscopy, echoplanar diffusion and diffusion-weighted MRI. Neuroradiology 2002; 44:656-666.
12. Kim YJ, Chang KH, Song IC, et al. Brain abscess and necrotic or cystic brain tumor: discrimination with signal intensity on diffusion-weighted MR imaging. AJR Am J Roentgenol 1998; 171:1487-1490.
13. Chang S-C, Lai P-H, Chen W-L, et al. Diffusion-weighted MRI features of brain abscesses and cystic or necrotic brain tumors. Comparison with conventional MRI. J Clin Imag 2002; 26:227-236.
14. Guzman R, Barth A, Lõvblad K-O, et al. Use of diffusion-weighted magnetic resonance imaging in differentiating purulent brain process from cystic brain tumours. J Neurosurg 2002; 97:1101-1107.
15. Geijer B, Holtås S. Diffusion-weighted imaging of brain metastases: their potential to be interpreted as focal ischaemic lesions. Neuroradiology 2002; 44:568-573.
16. Sugahara T, Korogi Y, Kochi M, et al. Correlation of MR imaging-determined cerebral blood volume maps with histological and angiographic determination of vascularity of gliomas. AJR Am J Roentgenol 1998; 171:1479-1486.
17. Lefournier V, Peoc'h M, Usson Y, et al. Magnetic resonance cerebral blood volume maps. Comparison with histologic findings in different types of brain lesions [in French]. J Neuradiol 2003; 30:3-9.
18. Knopp EA, Cha S, Johnson G, et al. Glial neoplasms: dynamic Contrast-enhanced T2*-weighted MR imaging. Radiology 1999; 211:791-798.
19. Lam W-W, Chan K-W, Wong W-L, et al. Preoperative grading of intracranial glioma. Comparison of MR-determined cerebral blood volume maps with thallium-201 SPECT. Acta Radiol 2001; 42:548-554.
20. Fuss M, Wenz F, Essig M, et al. Tumor angiogenesis of low-grade astrocytomas measured by dynamic susceptibility contrast-enhanced MRI (DSC-MRI) is predictive of local tumor control after radiation therapy. Int J Radiat Oncol Biol Phys 2001; 51:478-482.
21. Kremer S, Grand S, Remy C, et al. Cerebral blood volume mapping by MR imaging in the initial evaluation of brain tumors. J Neuroradiol 2002; 29:105-113. This large study compared rCBV values for different brain tumours and showed that CBV mapping provides additional information about tumour vascularity.
22. Kremer S, Grand S, Berger F, et al. Dynamic contrast-enhanced MRI: differentiating melanoma and renal carcinoma metastases from high-grade astrocytomas and other metastases. Neuroradiology 2003; 45:44-49.
23. Hartmann M, Heiland S, Harting I, et al. Distinguishing primary cerebral lymphoma from high-grade glioma with perfusion-weighted magnetic resonance imaging. Neurosci Lett 2003; 338:119-122.
24. Schneider JP, Dietrich J, Lieberenz, et al. Preliminary experience with interactive guided brain biopsies using a vertically opened 0.5-T MR system. Eur Radiol 1999; 9:230-236.
25. Bernays RL, Kollias SS, Khan N, et al. Histological yield, complications and technological considerations in 114 consecutive frameless stereotactic biopsy procedures aided by open intraoperative magnetic resonance imaging. J Neurosurg 2002; 97:354-362. This is a definitive description and evaluation of a new technology, namely iMRI, which shows that this technique has the potential to revolutionize a blind procedure into one that is adaptable to dynamic anatomical changes.
26. Nimsky C, Ganslandt O, Tomandl B, et al. Low-field magnetic resonance imaging for intraoperative use in neurosurgery: a 5-year experience. Eur Radiol 2002; 12:2690-2703.
27. Kahn T. Intraoperative MRI in neurosurgery: becoming mature. Eur Radiol 2002; 12:2617-2618.
28. Sobottka S, Bredow J, Beuthien-Baumann B, et al. Comparison of functional brain PET images and intraoperative brain-mapping data using image-guided surgery. Comput Aided Surg 2002; 7:317-325.
29. Ulmer JL, Krouwer HG, Mueller WM. Pseudo-reorganization of language cortical function at fMR imaging: a consequence of tumor-induced neurovascular uncoupling. AJNR Am J Neuroradiol 2003; 24:213-217.
30. Schiffbauer H, Ferrari P, Rowley HA. Functional activity with brain tumors: a magnetic source imaging study. Neurosurgery 2001; 49:1313-1321.
31. Pierpaoli C, Jezzard P, Basser PJ, et al. Diffusion tensor MR imaging of the human brain. Radiology 1996; 201:637-648.
32. Pajevic S, Pierpaoli C. Color schemes to represent the orientation of anisotropic tissues from diffusion tensor data: application to white matter fiber tract mapping in the human brain. Magn Res Med 1999; 42:526-540.
33. Witwer BP, Moftakhar R, Hasan KM, et al. Diffusion-tensor imaging of white matter tracts in patients with cerebral neoplasm. J Neurosurg 2002; 97:568-575. This is an excellent and comprehensible account of a new technique that is pertinent to gliomas because of their infiltrating biology.
34. Price SJ, Burnet NG, Donovan T, et al. Diffusion tensor imaging of brain tumours at 3T: a potential tool for assessing white matter tract invasion. Clin Radiol 2003; 58:455-462. This is an interesting study that suggests significant differences in tumour behaviour as seen on DTI between high-grade and low-grade gliomas.
35. Sinha S, Bastin ME, Whittle IR, Wardlaw JM. Diffusion tensor MR imaging of high-grade cerebral gliomas. AJNR Am J Neuroradiol 2002; 23:520-527.
36. Swanson KR, Alvord EC Jr, Murray JD. Virtual brain tumours (gliomas) enhance the reality of medical imaging and highlight inadequacies of current therapy. Br J Cancer 2002; 86:14-18.